MedTrace Logo

Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

NCT00915928 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2020-08-19

Study results available
· View outcomes & findings →

Summary

The project aims at investigating if treatment with the Angiotensin Converting Enzyme inhibitor Coversyl (perindopril) for 3 months after surgery for chronic subdural hematoma will decrease the risc of recurrence.

Conditions

  • Hematoma, Subdural, Chronic

Interventions

DRUG

Perindopril

2,5 mg daily for 3 months

DRUG

Placebo

Placebo dayli for 3 months

Sponsors & Collaborators

  • Alice Brenaa Foundation

    collaborator OTHER

  • The Hede Nielsen Family Foundation

    collaborator OTHER

  • Overlægerådets legatudvalg

    collaborator UNKNOWN

  • University of Southern Denmark

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Frantz R Poulsen, MD, PhD · Department of Neurosurgery, Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-05-31
Completion
2012-06-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00915928 on ClinicalTrials.gov